Literature DB >> 17135179

Evaluation of a combined online and in person training in the use of buprenorphine.

Erik W Gunderson1, David A Fiellin, Frances R Levin, Lynn E Sullivan, Herbert D Kleber.   

Abstract

To evaluate buprenorphine training methodology, we surveyed physicians who had completed a combined online and in person buprenorphine curriculum. Of 53/70 (76%) survey respondents, 57% were psychiatrists and 40% generalists. On a scale of 1 (very poor) to 7 (superlative), the overall training rated a mean of 5.8. The online course (5.0) rated lower than in person training components (p < .001) except for material that addressed the logistics of office practice. The in person patient interview received the highest rating (mean 6.3, p < .001). The 67% of physicians who intended to prescribe buprenorphine after the training were more likely than hesitant physicians to agree that the course provided enough information (p < .05) and that telephone access to experienced providers would improve their confidence (p < .05). Physicians hesitant to prescribe cited lack of experience as the main barrier (41%), with 24% concerned about induction difficulty and reimbursement. Overall, physicians preferred in person instruction and may benefit from additional experiential training and support after curriculum participation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17135179      PMCID: PMC3864017          DOI: 10.1300/J465v27n03_06

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  5 in total

1.  Screening and intervention for illicit drug abuse: a national survey of primary care physicians and psychiatrists.

Authors:  P D Friedmann; D McCullough; R Saitz
Journal:  Arch Intern Med       Date:  2001-01-22

2.  Training primary health care professionals to provide buprenorphine and LAAM treatment.

Authors:  Nicholas Lintzeris; Alison Ritter; Adrian Dunlop; Peter Muhleisen
Journal:  Subst Abus       Date:  2002-12       Impact factor: 3.716

3.  Office-based practice and opioid-use disorders.

Authors:  H Westley Clark
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245

Review 4.  Clinical practice. Office-based treatment of opioid-dependent patients.

Authors:  David A Fiellin; Patrick G O'Connor
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

5.  Faculty development in small-group teaching skills associated with a training course on office-based treatment of opioid dependence.

Authors:  Jeffrey G Wong; Eric S Holmboe; Gail B Jara; Judith Martin; William C Becker; David A Fiellin
Journal:  Subst Abus       Date:  2004-12       Impact factor: 3.716

  5 in total
  16 in total

1.  Improving temporal efficiency of outpatient buprenorphine induction.

Authors:  Erik W Gunderson; Frances R Levin; Margaret M Rombone; Suzanne K Vosburg; Herbert D Kleber
Journal:  Am J Addict       Date:  2011-07-18

Review 2.  Office-based maintenance treatment of opioid dependence: how does it compare with traditional approaches?

Authors:  Erik W Gunderson; David A Fiellin
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

Review 3.  Training physicians to treat substance use disorders.

Authors:  Soteri Polydorou; Erik W Gunderson; Frances R Levin
Journal:  Curr Psychiatry Rep       Date:  2008-10       Impact factor: 5.285

4.  Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program.

Authors:  Pooja A Shah; Nancy L Sohler; Carolina López; Aaron D Fox; Chinazo O Cunningham
Journal:  J Opioid Manag       Date:  2013 Nov-Dec

5.  I heard about it from a friend: assessing interest in buprenorphine treatment.

Authors:  Aaron D Fox; Pooja A Shah; Nancy L Sohler; Carolina M Lopez; Joanna L Starrels; Chinazo O Cunningham
Journal:  Subst Abus       Date:  2014       Impact factor: 3.716

6.  Expanding treatment for opioid use disorder in publicly funded primary care clinics: Exploratory evaluation of the NYC health + hospitals buprenorphine ECHO program.

Authors:  Babak Tofighi; Noah Isaacs; Hannah Byrnes-Enoch; Rebecca Lakew; Joshua D Lee; Carolyn Berry; Daniel Schatz
Journal:  J Subst Abuse Treat       Date:  2019-08-09

7.  The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment.

Authors:  James E Egan; Paul Casadonte; Tracy Gartenmann; Judith Martin; Elinore F McCance-Katz; Julie Netherland; John A Renner; Linda Weiss; Andrew J Saxon; David A Fiellin
Journal:  J Gen Intern Med       Date:  2010-05-11       Impact factor: 5.128

8.  Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.

Authors:  Rebecca L Haffajee; Amy S B Bohnert; Pooja A Lagisetty
Journal:  Am J Prev Med       Date:  2018-06       Impact factor: 5.043

9.  Cost-effectiveness of an internet-delivered treatment for substance abuse: Data from a multisite randomized controlled trial.

Authors:  Sean M Murphy; Aimee N C Campbell; Udi E Ghitza; Tiffany L Kyle; Genie L Bailey; Edward V Nunes; Daniel Polsky
Journal:  Drug Alcohol Depend       Date:  2016-01-30       Impact factor: 4.492

10.  A buprenorphine education and training program for primary care residents: implementation and evaluation.

Authors:  Hillary V Kunins; Nancy L Sohler; Angela Giovanniello; Devin Thompson; Chinazo O Cunningham
Journal:  Subst Abus       Date:  2013       Impact factor: 3.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.